Nanoform Finland Oyj (HEL:NANOFH) Third Quarter 2022 Results
Key Financial Results
- Net loss: €5.16m (loss widened by 14% from 3Q 2021).
- €0.07 loss per share (further deteriorated from €0.06 loss in 3Q 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nanoform Finland Oyj EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 23%. Earnings per share (EPS) exceeded analyst estimates by 53%.
Looking ahead, revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Europe.
The company's shares are down 5.9% from a week ago.
You still need to take note of risks, for example - Nanoform Finland Oyj has 2 warning signs we think you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Nanoform Finland Oyj is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.View the Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.